Dr. Adi Elkeles is a Senior Executive who has a proven track record in leading biomed entrepreneurship and innovation for close to 20 years. Having held key executive positions in several biotechnology companies, he managed the development of technologies from early pre-clinical stages through market approval and sales, led numerous business and licensing deals, and strategic development activities. Prior to founding Trobix Bio, Adi served as VP Business Development at Ramot, the Technology Transfer Office of Tel Aviv University where he led business development, licensing and strategy for the Life Sciences sector.
Before joining Ramot, Adi was Chief Technology Officer and Chief Business Development Officer at Micromedic, a cancer diagnostic cluster company. In this role, he led commercialization, in licensing and out licensing activities.
Previously, Adi served as CEO of Zetiq Technologies Ltd., a cancer diagnostic company, where he advanced the company from the pre-clinical stage to the point of having a fully commercial product and a portfolio of pipeline products in the clinical stage. Preceding Zetiq, Adi held several managerial positions leading pre-clinical development programs for anti-cancer at BiolineRx, a technology incubator as well as leading programs for infectious diseases at XTLbio.
Adi holds a PhD from Tel Aviv University, an MBA from the College of Management, and he completed his post-doctoral fellowship at the Weizmann Institute of Science, Israel. Adi is an alumnus of the Paul Merage Life Science Executive Leadership Program of UC Irvine, California.